StockData

Addus HomeCare vs AdaptHealth

ADUS and AHCO side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ADUS and AHCO compare

Addus HomeCare is the larger company, worth 2.2 times as much as AdaptHealth ($2.3B against $1.0B).

Addus HomeCare grew revenue faster over the last twelve months (15.9% versus 4.2% for AdaptHealth).

Addus HomeCare keeps more of each dollar of sales as profit, with a net margin of 7.1% compared with −7.1% at AdaptHealth.

Addus HomeCare scores higher on the StockData Score (20 against 6 for AdaptHealth), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricADUSAHCO
Size and price
Market cap$2.3B$1.0B
Share price$121.56$7.53
Change, 1 year11.5%−18.1%
Change, 5 years33.0%−65.1%
Beta (5Y)0.28−1.46
Employees5,29011K
StockData Score
Total score20 (better)6
Valuation score5 (better)3
Growth score4 (better)0
Performance score5 (better)0
Health score6 (better)3
Dividend score00
Valuation
P/E21.3×–
P/S1.5×0.3× (better)
P/B2.0×0.7× (better)
EV/EBITDA13.5×10.5× (better)
P/FCF14.7×10.5× (better)
PEG0.95–
FCF yield6.8%9.5% (better)
Fair value$137.11$13.48
Margin of safety11.3%44.1% (better)
Growth
Revenue growth (TTM)15.9% (better)4.2%
Revenue growth, 5Y average13.2%25.2% (better)
Net income growth (TTM)26.9% (better)−383%
EPS growth (TTM)25.8% (better)−419%
EPS growth, 5Y average20.2%–
Profitability
Gross margin32.4% (better)17.0%
Operating margin10.0% (better)−4.5%
Net margin7.1% (better)−7.1%
FCF margin10.5% (better)3.0%
Return on equity9.7% (better)−15.4%
Return on invested capital10.0% (better)−3.4%
Financial health
Debt / equity0.05 (better)1.37
Net debt / EBITDA−0.236.79 (better)
Interest coverage14.9×–
Current ratio1.69 (better)1.12
Altman Z-score6.37 (better)0.61
Piotroski F-score6 (better)4
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions104%104%
Held by insiders2.8%14.7%
Insider net buying, 12 months−$20.7M$49.1M (better)
Short interest, % of float5.5%9.4%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.